Outcomes for patients with hematologic malignancy infected with COVID-19 have not been
aggregated. The objective of this study was to perform a systematic review and meta …

Background Patients from ethnic minority groups are disproportionately affected by
Coronavirus disease (COVID-19). We performed a systematic review and meta-analysis to …

Several studies have revealed that the hyper-inflammatory response induced by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major cause of disease …

The linkage of individuals with obesity and COVID‐19 is controversial and lacks systematic
reviews. After a systematic search of the Chinese and English language literature on COVID …

Background Patients with coronavirus disease 2019 (COVID-19) who have underlying
malignancy have a higher mortality rate compared with those without cancer, although the …

The presence of SARS-CoV-2 was officially documented in Europe at the end of February
2020. Despite many observations, the real impact of COVID-19 in the European Union (EU) …

Aims To estimate the association of smoking status with rates of (i) infection,(ii)
hospitalization,(iii) disease severity and (iv) mortality from SARS‐CoV‐2/COVID‐19 disease …

Background Patients with cancer have been shown to have a higher risk of clinical severity
and mortality compared to non-cancer patients with COVID-19. Patients with hematologic …

Importance Patients who are immunocompromised have increased risk for morbidity and
mortality associated with coronavirus disease 2019 (COVID-19) because they less …

The primary cause of morbidity and mortality in patients with multiple myeloma (MM) is an
infection. Therefore, there is great concern about susceptibility to the outcome of COVID-19 …